Literature DB >> 32189470

Novel stimulation strategy with autologous tumor cells to generate T cell receptor-engineered T cells in esophageal squamous cell carcinoma.

Liyi Zhang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32189470      PMCID： PMC7180585          DOI： 10.1111/1759-7714.13404

Source DB:  PubMed          Journal:  Thorac Cancer        ISSN： 1759-7706            Impact factor:   3.500


× No keyword cloud information.
  16 in total

1.  Noncoding regions are the main source of targetable tumor-specific antigens.

Authors:  Céline M Laumont; Krystel Vincent; Leslie Hesnard; Éric Audemard; Éric Bonneil; Jean-Philippe Laverdure; Patrick Gendron; Mathieu Courcelles; Marie-Pierre Hardy; Caroline Côté; Chantal Durette; Charles St-Pierre; Mohamed Benhammadi; Joël Lanoix; Suzanne Vobecky; Elie Haddad; Sébastien Lemieux; Pierre Thibault; Claude Perreault
Journal:  Sci Transl Med       Date:  2018-12-05       Impact factor: 17.956

Review 2.  'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations.

Authors:  Eric Tran; Paul F Robbins; Steven A Rosenberg
Journal:  Nat Immunol       Date:  2017-02-15       Impact factor: 25.606

3.  Tumor-infiltrating BRAFV600E-specific CD4+ T cells correlated with complete clinical response in melanoma.

Authors:  Joshua R Veatch; Sylvia M Lee; Matthew Fitzgibbon; I-Ting Chow; Brenda Jesernig; Tom Schmitt; Ying Ying Kong; Julia Kargl; A McGarry Houghton; John A Thompson; Martin McIntosh; William W Kwok; Stanley R Riddell
Journal:  J Clin Invest       Date:  2018-03-12       Impact factor: 14.808

Review 4.  Epidemiology of Esophageal Squamous Cell Carcinoma.

Authors:  Christian C Abnet; Melina Arnold; Wen-Qiang Wei
Journal:  Gastroenterology       Date:  2017-08-18       Impact factor: 22.682

5.  Adoptive T-Cell Therapy for Solid Tumors.

Authors:  Oladapo Yeku; Xinghuo Li; Renier J Brentjens
Journal:  Am Soc Clin Oncol Educ Book       Date:  2017

6.  Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.

Authors:  Stephan A Grupp; Michael Kalos; David Barrett; Richard Aplenc; David L Porter; Susan R Rheingold; David T Teachey; Anne Chew; Bernd Hauck; J Fraser Wright; Michael C Milone; Bruce L Levine; Carl H June
Journal:  N Engl J Med       Date:  2013-03-25       Impact factor: 91.245

7.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

Review 8.  Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells.

Authors:  Jean-François Rossi; Patrice Céballos; Zhao-Yang Lu
Journal:  Cancer Commun (Lond)       Date:  2019-06-14

9.  Isolation of T cell receptor specifically reactive with autologous tumour cells from tumour-infiltrating lymphocytes and construction of T cell receptor engineered T cells for esophageal squamous cell carcinoma.

Authors:  Qin Tan; Chaoting Zhang; Wenjun Yang; Ying Liu; Palashati Heyilimu; Dongdong Feng; Liying Xing; Yang Ke; Zheming Lu
Journal:  J Immunother Cancer       Date:  2019-08-28       Impact factor: 13.751

Review 10.  The immune landscape of esophageal cancer.

Authors:  Tu-Xiong Huang; Li Fu
Journal:  Cancer Commun (Lond)       Date:  2019-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.